News
CorTec Implants Second Patient in European BCI Push
German neurotechnology firm CorTec has completed its second human implantation, advancing its position in the competitive brain-computer interface market alongside U.S. rivals.
News
8 articles
News
Blind Korean YouTuber Volunteers for Neuralink's Blindsight Trial
Kim Han-sol, a blind YouTuber with 1.68 million subscribers, has publicly applied for Neuralink's Blindsight clinical trial, bringing significant public attention to the experimental vision-restoring brain implant.
News
Indian Child Regains Hearing Through Brainstem Neural Implant
AIIMS Delhi performs first auditory brainstem implant in India, demonstrating neural bypass technology's potential for patients unsuitable for conventional cochlear devices.
News
Wireless Retinal Implant Restores Vision in 80% of Trial Participants
A major clinical trial shows wireless neural implants restored meaningful central vision to those blinded by macular degeneration, with participants reading letters and words.
News
Living Neurons Learn Doom in a Week, Signaling New Era
Cortical Labs demonstrated human brain cells on a chip mastering basic gameplay within seven days, advancing the case for biological computing in real-world applications.
News
Neuralink Enrolls 21 Trial Participants in Human Implant Study
Elon Musk's brain-computer interface company has now implanted 21 people with its neural device, marking a significant acceleration in its clinical trial timeline.
News
NeuroXess Completes Human Trials as China Accelerates BCI Race
Chinese BCI company NeuroXess has surpassed human trial milestones, positioning itself as a direct competitor to Neuralink in the global neural interface market.
News
Nicolelis Study in China Shows Brain Reorganization Restores Movement
Brazilian neuroscientist Miguel Nicolelis leads research with Chinese collaborators demonstrating that brain-computer interface technology can trigger neural reorganization and restore movement in paralyzed patients.
Stay Ahead of the Curve
Get the latest BCI news, breakthroughs, and market moves delivered to your inbox.
No spam. Unsubscribe anytime. We respect your privacy.